Esch et al., 2015 - Google Patents
Organs-on-chips at the frontiers of drug discoveryEsch et al., 2015
View HTML- Document ID
- 481750562893972425
- Author
- Esch E
- Bahinski A
- Huh D
- Publication year
- Publication venue
- Nature reviews Drug discovery
External Links
Snippet
Improving the effectiveness of preclinical predictions of human drug responses is critical to reducing costly failures in clinical trials. Recent advances in cell biology, microfabrication and microfluidics have enabled the development of microengineered models of the …
- 238000007876 drug discovery 0 title abstract description 28
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Esch et al. | Organs-on-chips at the frontiers of drug discovery | |
Sun et al. | Recent advances in microfluidics for drug screening | |
Jiang et al. | Recent progress in microfluidic models of the blood-brain barrier | |
Regmi et al. | Applications of microfluidics and organ-on-a-chip in cancer research | |
Zhao et al. | Multi-organs-on-chips: towards long-term biomedical investigations | |
Jalili-Firoozinezhad et al. | Modeling the human body on microfluidic chips | |
Ramadan et al. | Organ-on-a-chip engineering: Toward bridging the gap between lab and industry | |
Aziz et al. | The role of microfluidics for organ on chip simulations | |
Rogal et al. | Integration concepts for multi-organ chips: how to maintain flexibility?! | |
Marx et al. | Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing | |
Chi et al. | Microfluidic cell chips for high-throughput drug screening | |
Perestrelo et al. | Microfluidic organ/body-on-a-chip devices at the convergence of biology and microengineering | |
Sung et al. | Using physiologically-based pharmacokinetic-guided “body-on-a-chip” systems to predict mammalian response to drug and chemical exposure | |
Farahat et al. | Ensemble analysis of angiogenic growth in three-dimensional microfluidic cell cultures | |
Liu et al. | Cell-based assays on microfluidics for drug screening | |
Dehne et al. | The ascendance of microphysiological systems to solve the drug testing dilemma | |
Kashaninejad et al. | Organ-tumor-on-a-chip for chemosensitivity assay: a critical review | |
Van Der Meer et al. | Organs-on-chips: breaking the in vitro impasse | |
Lee et al. | Organ‐on‐a‐chip technology and microfluidic whole‐body models for pharmacokinetic drug toxicity screening | |
Toh et al. | Engineering microfluidic concentration gradient generators for biological applications | |
Kim et al. | 96-well format-based microfluidic platform for parallel interconnection of multiple multicellular spheroids | |
Cardoso et al. | Recent advances on cell culture platforms for in vitro drug screening and cell therapies: from conventional to microfluidic strategies | |
Dai et al. | Microfluidics for antibiotic susceptibility and toxicity testing | |
Ko et al. | Engineering organ-on-a-chip to accelerate translational research | |
Ustun et al. | Glioma-on-a-chip models |